Rankings
▼
Calendar
PTCT Q2 2025 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
PTCT
PTC Therapeutics, Inc.
$6B
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$179M
-4.2% YoY
Gross Profit
$167M
93.6% margin
Operating Income
-$35M
-19.5% margin
Net Income
-$65M
-36.3% margin
EPS (Diluted)
$-0.83
QoQ Revenue Growth
-84.8%
Cash Flow
Operating Cash Flow
-$58M
Free Cash Flow
-$62M
Stock-Based Comp.
$19M
Balance Sheet
Total Assets
$2.6B
Total Liabilities
$2.8B
Stockholders' Equity
-$207M
Cash & Equivalents
$1.0B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$179M
$187M
-4.2%
Gross Profit
$167M
$171M
-2.2%
Operating Income
-$35M
-$40M
+13.1%
Net Income
-$65M
-$99M
+34.6%
Revenue Segments
Product
$118M
66%
Royalty
$58M
32%
Collaboration and License Revenue
$3M
2%
Geographic Segments
Non-US
$82M
69%
United States
$36M
31%
← FY 2025
All Quarters
Q3 2025 →